In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure–activity relationships and molecular docking |
| |
摘 要: |
|
收稿时间: | 13 September 2018 |
本文献已被 ScienceDirect 等数据库收录! |
|